Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Walgreens Boots Alliance, Inc.WBA · Entity 16467 | Director | August 13, 2025 | August 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Walgreens Boots Alliance, Inc.
Report date August 13, 2025 · Filed August 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 16,820.86 |
Reported balance
After 2025-08-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-08-13 · Grant · Acquired 16,820.86 · Balance 16,820.86 F1: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock.
F2: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date August 05, 2022 · Filed August 05, 2022
Section 16 reporting ended · disclosed 2022-08-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 4,294 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,294 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $248.01 · Expires 2026-05-01 | Direct | 6,842 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 6,842 F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $350.79 · Expires 2027-02-24 | Direct | 5,372 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 5,372 F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $376.61 · Expires 2028-02-22 | Direct | 4,057 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 4,057 F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $425.06 · Expires 2029-02-21 | Direct | 3,165 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 3,165 F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 357 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 357 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 658 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 658 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 873 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 873 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22.
F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F6: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
F7: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
F8: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
WW INTERNATIONAL, INC.
Report date June 24, 2025 · Filed June 26, 2025
Section 16 reporting ended · disclosed 2025-06-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 225 |
Ending reported balance
After 2025-06-24 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-06-24 · Exercise / conversion · Acquired 20,795 · Balance 20,795 F1: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. F3: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below). Row 2 · 2025-06-24 · Disposition to issuer · Disposed 20,795 · Balance 0 F4: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Row 3 · 2025-06-24 · Grant · Acquired 225 · Balance 225 F4: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-06-24 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-06-24 · Exercise / conversion · Disposed 20,795 · Balance 0 F1: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F3: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below). F2: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.
F2: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.
F3: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below).
F4: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2025 Filed Aug 15, 2025 18:01 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 16,820.86 | $11.89 | $200,000.03 |
DisclosureSEC source: 0001618921-25-000080 · wk-form4_1755295313.xml · derivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,820.86 Underlying: Common Stock · 16,820.86 shares Expires not disclosed F1 · derivative.exercise_price: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:57 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | Exercise / conversionDeferred Stock Unit · Derivative | 20,795 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-090485 · ownership.xml · derivative · entry 4 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,795 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F3 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below). F1 · kind: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · kind: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. F1 · shares: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · shares: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. F1 · price: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · price: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. F2 · derivative.exercise_date: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. F2 · derivative.expiration_date: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:57 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-090485 · ownership.xml · nonDerivative · entry 3 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225 F4 · shares: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. F4 · price: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:57 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | Disposition to issuerCommon Stock | 20,795 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-090485 · ownership.xml · nonDerivative · entry 2 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F4 · shares: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. F4 · price: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:57 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | Exercise / conversionCommon Stock | 20,795 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-090485 · ownership.xml · nonDerivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · shares: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. F1 · price: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · price: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full. F3 · price: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below). Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 21:01 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantDeferred Stock Unit · Derivative | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-000392 · ownership.xml · derivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,795 Underlying: Common Stock · 3,696 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 20:59 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 3,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-24-000131 · wk-form4_1730858380.xml · nonDerivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,523 F1 · kind: Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder). Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:01 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantDeferred Stock Unit · Derivative | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111404 · ownership.xml · derivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,099 Underlying: Common Stock · 3,696 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:42 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantDeferred Stock Unit · Derivative | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-081585 · ownership.xml · derivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,403 Underlying: Common Stock · 3,696 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:25 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantDeferred Stock Unit · Derivative | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-041098 · ownership.xml · derivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,707 Underlying: Common Stock · 3,696 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:55 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantDeferred Stock Unit · Derivative | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001040 · ownership.xml · derivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,011 Underlying: Common Stock · 3,696 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:08 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantDeferred Stock Unit · Derivative | 2,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051903 · doc4.xml · derivative · entry 1 Shrank William H · CIK 0001772348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,315 Underlying: Common Stock · 2,315 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · derivative · entry 9 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 164 | $449.81 | $73,769.58 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 4 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,294 F11 · shares: Shares disposed of represent withholding of taxes on restricted/performance stock unit vesting. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 3 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 2,250 | $449.81 | $1,012,082.63 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 2 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,954 F11 · shares: Shares disposed of represent withholding of taxes on restricted/performance stock unit vesting. Read SEC document |
| May 01, 2022 Filed May 3, 2022 17:45 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 4,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 1 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Includes Performance Stock Units, not required to be reported until vest. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:35 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 873 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005393 · form4.xml · derivative · entry 9 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 873 Underlying: Humana Common · 873 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:35 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 3,165 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005393 · form4.xml · derivative · entry 5 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,165 Underlying: Humana Common · 3,165 shares Expires 2029-02-21 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:23 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 328 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013085 · form4.xml · derivative · entry 10 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658 Underlying: Humana Common · 328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:23 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013085 · form4.xml · derivative · entry 9 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357 Underlying: Humana Common · 356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:23 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 156 | $459.85 | $71,736.60 |
DisclosureSEC source: 0001062993-21-013085 · form4.xml · nonDerivative · entry 4 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:23 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 328 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013085 · form4.xml · nonDerivative · entry 3 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:23 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 170 | $459.85 | $78,174.50 |
DisclosureSEC source: 0001062993-21-013085 · form4.xml · nonDerivative · entry 2 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:23 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013085 · form4.xml · nonDerivative · entry 1 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2021 Filed May 4, 2021 15:11 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000087 · edgar.xml · derivative · entry 6 Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504 Underlying: Humana Common · 504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. Read SEC document |
| May 01, 2021 Filed May 4, 2021 15:11 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 164 | $446.12 | $73,162.86 |
DisclosureSEC source: 0000049071-21-000087 · edgar.xml · nonDerivative · entry 2 Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920 Read SEC document |
| May 01, 2021 Filed May 4, 2021 15:11 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000087 · edgar.xml · nonDerivative · entry 1 Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 986 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000060 · edgar.xml · derivative · entry 7 Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 986 Underlying: Humana Common · 986 shares Expires not disclosed F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 4,057 | $0.00 Strike: $376.61 | $0.00 |
DisclosureSEC source: 0000049071-21-000060 · edgar.xml · derivative · entry 4 Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,057 Underlying: Humana Common · 4,057 shares Expires 2028-02-22 F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 16:49 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000163 · edgar.xml · derivative · entry 6 Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713 Underlying: Humana Common · 356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 16:49 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 116 | $390.49 | $45,296.26 |
DisclosureSEC source: 0000049071-20-000163 · edgar.xml · nonDerivative · entry 2 Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580 Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 16:49 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000163 · edgar.xml · nonDerivative · entry 1 Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:01 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000084 · edgar.xml · derivative · entry 5 Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,008 Underlying: Humana Common · 504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. F4 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:01 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 164 | $373.20 | $61,205.29 |
DisclosureSEC source: 0000049071-20-000084 · edgar.xml · nonDerivative · entry 2 Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340 Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:01 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000084 · edgar.xml · nonDerivative · entry 1 Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 22:24 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000047 · edgar.xml · derivative · entry 5 Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069 Underlying: Humana Common · 1,069 shares Expires not disclosed F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 22:24 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 5,372 | $0.00 Strike: $350.79 | $0.00 |
DisclosureSEC source: 0000049071-20-000047 · edgar.xml · derivative · entry 3 Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,372 Underlying: Humana Common · 5,372 shares Expires 2027-02-24 F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. Read SEC document |
| May 01, 2019 Filed May 2, 2019 18:54 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 1,512 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000062 · edgar.xml · derivative · entry 3 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,512 Underlying: Humana Common · 1,512 shares Expires not disclosed F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22. Read SEC document |
| May 01, 2019 Filed May 2, 2019 18:54 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 6,842 | $0.00 Strike: $248.01 | $0.00 |
DisclosureSEC source: 0000049071-19-000062 · edgar.xml · derivative · entry 2 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,842 Underlying: Humana Common · 6,842 shares Expires 2026-05-01 F1 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.